| (Values in U.S. Thousands) | Sep, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sep, 2023 |
| Sales | 9,210 | 7,520 | 3,750 | 4,760 | 5,080 |
| Sales Growth | +22.47% | +100.53% | -21.22% | -6.30% | -14.77% |
| Net Income | -970 | -1,120 | -3,840 | -2,460 | -2,030 |
| Net Income Growth | +13.39% | +70.83% | -56.10% | -21.18% | -100.99% |
Myomo Inc (MYO)
5.26 -0.17 (-3.13%) 09:54 ET [NYSE Arca]
5.17 x 25,600 5.25 x 300
Realtime by (Cboe BZX)
5.17 x 25,600 5.25 x 300
Realtime 5.81 +0.38 (+7.00%) 09:25 ET
for Thu, Mar 13th, 2025
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
Fiscal Year End Date: 12/31